New Project (1)

Day: February 15, 2022

Imperial Capital Hires Senior Hybrids Trader Scott Wilson to Expand European Financials Business

LOS ANGELES, Feb. 15, 2022 (GLOBE NEWSWIRE) — Imperial Capital Group, LLC (“Imperial Capital”) announced today that it has hired Scott Wilson to trade European financials across the firm’s global network. The move represents Imperial’s continued growth strategy in order to augment the firm’s global credit offerings to institutional investors, specifically in the global financials […]

Read More »

HqO’s Rapid Deployment Capabilities Enable Office Owners to Quickly Modernize and Provide Flexible, Experiential Workplaces

Recent Launches Bring Global Workplace Solutions to More than 200 Million Square Feet of Real Estate BOSTON, Feb. 15, 2022 (GLOBE NEWSWIRE) — HqO, the industry-leading workplace experience technology platform that is revolutionizing how people connect with each other and the places they work, has launched 53 new customer properties in the last six months […]

Read More »

SEKO Logistics Streamlines International Cross-Border Ecommerce Using Descartes Solutions

ATLANTA, Feb. 15, 2022 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that SEKO Logistics is using Descartes’ solutions for air cargo security filings and ecommerce customs clearance to speed processing time for more than 10 million parcels worldwide each month. “Cross-border ecommerce is […]

Read More »

Innovation in Natural, Clean Ingredients Ushers in Sensegen

Beautiful biotechnology meets the science of good sense Rancho Santa Margarita, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) — Sensegen,  southern California’s new taste, smell, and beauty business, enters the ingredient market as the first 100% biotechnology-based solution provider serving these markets. Emerging as The Science of Good Sense™, Sensegen’s brand launch marks an 18-month incubation […]

Read More »

Positive Results for Lipid inCode® in NHS Clinical Study

Lipid inCode® offers greater diagnostic information for hypercholesterolemia sufferers over current NHS standard Featured Image for GENinCode Plc OXFORD, England, Feb. 15, 2022 (GLOBE NEWSWIRE) — GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the successful completion of its NHS clinical study and positive results for its Lipid […]

Read More »


 Recent Post


February 2022